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Summary 
The Fc receptors (FcR), which belong to the immunoglobulin (Ig) superfamily, bind to spe- 
cific Ig isotypes with varying affinities  triggering complex immune defense responses. Several 
of the Fctk that lack signaling motifs in their cytoplasmic domains rely on associated subunits to 
transmit signals. Two classes of Fctk that bind the Fc portion oflgG, FcyRI, and FcytklIIa as- 
sociate with a subunit shared among several FcR, the y  chain, which is involved in receptor 
expression and signal transduction. In this report, we propose that a novel role for y chain is to 
enhance the affinity of Fcytk for ligand. Our findings demonstrate that FcytkI requires y-chain 
association  to attain high affinity binding for monomeric IgG, and suggest that the intermediate 
binding affinity of the FcyIklIIa isoform results  from its association with y  chain. The affinity 
increase conferred by y  chain appears to be mediated through the transmembrane domain of 
the Fcytk, with no requirement for the cytoplasmic domain of the receptor. 
T 
he Fc receptors (Fctk) 1, which bind the Fc region of 
Ig, provide an important link between cellular and hu- 
moral branches of the immune system by triggering several 
immune responses including phagocytosis, endocytosis, an- 
tibody-dependent cytotoxicity, release of inflammatory me- 
diators, and enhancement of antigen presentation upon im- 
mune complex-mediated clustering (1, 2). Three classes of 
receptors for  IgG  (Fcytk)  have  been  identified--FcyRI, 
FcytklI, and Fcyl~.-III--and all but one are integral mem- 
brane proteins constituted ofglycosylated extracellular Ig-like 
domains, a short transrnembrane domain, and a cytoplasmic 
domain. FcytklIIb is not a transmembrane receptor, since it 
is anchored to the membrane by a glycosyl phosphatidyli- 
nositol (GPI) link.  FcyRI is  distinguished from the  other 
Fcytk members in having a unique third extracellular do- 
main, while FcytklI and FcyP,  III are two extracellular do- 
main receptors. Fc',/RI and FcyRIIIa both associate  with y 
chain, a 20-kD disulfide-linked, homodimeric, signal-gen- 
erating subunit that also associates with the high affinity IgE 
FcR (FceRI) and the IgA FcR  (FcottL) (3-5).  In addition 
to functioning as a signal-transducing subunit, y  chain also 
plays a role in the cell-surface expression of some of these 
receptors; for example, FceR.I and the FcylLIIIa isoform re- 
quire association with y  chain for expression in COS cells 
(6, 7). Expression of FcylLI  and FcodL in eukaryotic cells, 
however, is independent of y-chain cotransfection (8, 9). 
FcyR. bind IgG with different affinities  and show class- 
1Abbreviations used in this paper: FctL, Fc receptor;  Fc0dk, IgA FcR; Fc',/tL, 
IgG Fctk; FcetL, IgE FcR; GPI, glycosyl  phosphatidylinositol;  Ka, equi- 
librium association constant; MFI, mean fluorescence  intensity. 
specific binding to IgG subtypes. A  defining characteristic 
of  FcyRI is its high affinity for monomeric IgG, while FcyRII 
and  FcytklIIb bind primarily immune  complexes, having 
low affinity for the monomeric ligand. The FcyRIIIa isoform 
binds monomeric IgG with an intermediate affinity that is 
lower than that of FcytkI but higher than that of FcyRIIIb 
and FcyRII (10). Although the high affinity binding of  FcytkI 
for monomeric IgG (K  a =  108-9 M -1)  (11,  12) has been at- 
tributed to the presence of the third extracellular domain 
(8,  13,  14),  FcylLI transfected into COS cells binds ligand 
with an affinity that is fivefold lower (K~ =  5.0 ￿  107 M -1) 
than that measured on cells that naturally express the recep- 
tor (8, 14). These results suggest that some factor(s), present 
in the cells that naturally express FcyRI and absent in COS 
cells, participates in the high affinity binding. Among these 
factors, one potential candidate is the y-chain subunit.  In 
the present study, we demonstrate that the affinity of both 
human  and  murine  FcyRl  increases  when  y  chain  is 
cotransfected with these receptors, and that the affinity in- 
crease correlates with association with y  chain and is inde- 
pendent of the cytoplasmic domain of FcytkI. We also ob- 
served that the intermediate affinity of FcyRIIIa appears to 
be dependent upon y-chain association. 
Materials and Methods 
Cells and Cell Culture.  U937,  a  human  monocyte  cell  line 
from American Type Culture Collection  (Rockville, MD), and 
N10F7,  a mouse 3T3 fibroblast cell line stably transfected with 
human  Fc~/RI eDNA,  were  maintained  in  RPMI  1640 (Life 
Technologies,  Gaithersburg, MD)  supplemented with  10% fetal 
bovine  serum  (Hyclone  Laboratories,  Logan,  UT),  2  mM 
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COS-7  cells  were  cultured  in  DMEM  with  the  supplements 
listed  above.  The  N10F7  medium  also  contained  0.5  mg/ml 
G418 (Life Technologies). U937 cells were cultured with 100 U/ml 
human rlFNy (Genentech, San Francisco, CA) 48 h before each 
experiment to increase FcyRI expression. 
Plasmid Constructs and Transfections.  The human FcyRI cDNA 
cloned into the pCDM vector was described by Ernst et al.  (3). 
The human y-chain cDNA in vector pSVL was a kind gift from 
Dr. Jean-Pierre Kinet  (National Institute of Allergy and  Infec- 
tious  Diseases,  Bethesda,  MD).  FcyRIIIb, FcyRIIIa, FcyRIIIa 
GPI,  and murine y-chain cDNAs were  all generous gifts from 
Dr. Jeffrey V. Ravetch (Memorial Sloan-Kettering Cancer Cen- 
ter,  New  York).  FcyRIIIa and  FcyRIIIb cDNA were  further 
subcloned in the vector pcDNA1  (Invitrogen, San Diego, CA). 
The murine FcyRI cDNA was a kind gift from Dr. Duane W. 
Sears  (University of California, Santa Barbara,  CA),  the  human 
macrophage mannose receptor cDNA in the vector pHMR was 
from Dr. Benjamin A. Kruskal (Children's Hospital, Boston, MA), 
and the pRSVCAT vector was from Dr. Lai-Chu Wu (The Ohio 
State University, Columbus,  OH).  A  truncated human  FcyRI, 
designated FF, was constructed by PCR amplification using FcyRl 
cDNA as a template, and truncation was confirmed by sequenc- 
ing. The FcyRI sense primer, containing a stop codon at the pre- 
dicted amino acid residue 319,  was  5'-GAC AAT ACG  TAA 
AGA ACT GAA ATG AAA GAA-3', and the antisense primer 
was 5'-ACT GAG CCG CTG CTA CGT GG-3'. The cDNAs 
were transiently transfected into COS-7 cells by the diethylami- 
noethyl-dextran method described previously (3), using 1-2 btg/ml 
DNA, and the cells were analyzed 48 h after transfection. 
Ligand-binding Assays and Scatchard Analysis.  Approximately  5 X 
10 s COS-7 cell transfectants or N10F7  cells per well were cul- 
tured in 24-well plates overnight to confluence. Cells were incu- 
bated in triplicate for 2-4  h  on ice with 0.15  ml of increasing 
concentrations  (0.5-10  or 30  Izg/ml) of monomeric  12sI-IgG2a 
labeled with an efficiency of 95% by the chloroglycouril method. 
After the cells were washed to remove unbound 12sI-IgG,  they 
were  solubilized in  0.5  ml  3  N  NaOH,  and  radioactivity was 
measured with a gamma scintillometer. For cells in  suspension, 
unbound ~2Sl-IgG was removed by centrifuging the cell suspen- 
sion through oil (bis(2-ethylhexyl)phthalate/dibutylphthalate  1:1.1), 
as previously described (11).  The nonspecific binding was deter- 
mined by the amount of radioactivity binding to wells containing 
mock-transfected COS-7 and untransfected 3T3,  or by incubat- 
ing the COS-7, N10F7 transfectants,  and U937 with radioligand 
in the presence of 100-fold excess unlabeled IgG2a. Both meth- 
ods of determining nonspecific binding resulted in  background 
counts  that  represented 0.1-0.3%  of the  input  of radioactivity. 
Binding data were analyzed using the Collection of Radioligand 
Binding  Analysis  Programs  (Elsevier-BIOSOFT,  Cambridge, 
UK). Results were expressed as the mean -  SEM of 3-13 exper- 
iments, and statistical analysis was performed using Student's t test. 
Immunoadsorption and Western Analysis.  Anti-FcyRI mAb 197 
(mlgG2a) was obtained from Me&rex (Annandale, NJ). The rab- 
bit anti-y-chain serum was a generous gift from Dr. Jean-Pierre 
Kinet  (National Institute of Allergy and Infectious Diseases),  as 
was the mAb anti-y-chain 4D8 from Dr. Jarema Kochan (Hoff- 
man-La Roche, Nutley, NJ). COS-7 transfectants were lysed for 
1-2 h  on ice in 1% digitonin (Calbiochem, San Diego, CA), 20 
mM  triethanolamine,  pH  7.8,  150  raN1 NaC1,  0.12%  Triton 
X-100,  and 2  mM  PMSF  (Sigma Immunochemicals, St.  Louis, 
MO),  and  clarified  supernatants  were  incubated  with  mAbs 
bound to Sepharose 4B  (Phannacia Fine Chemicals, Piscataway, 
NJ)  coupled to  goat F(ab')2 anti-mouse IgG  (Pierce Chemical 
Co., Rockford, IL), as previously described (3). Immunoadsorbed 
proteins, eluted by boiling in Laemmli sample buffer containing 
5% 2-mercaptoethanol, were separated by SDS-PAGE in parallel 
with  Rainbow  protein  molecular weight  markers  (Amersham 
Corp.,  Arlington Heights,  IL)  and  transferred to  nitrocellulose 
membranes. After blocking, the blots were incubated sequentially 
with 1/1,000 dilution of anti-y-chain rabbit serum and horserad- 
ish peroxidase-linked protein G (Bio Rad Laboratories, Hercules, 
CA) followed by enhanced chemiluminescence detection (ECL; 
Amersham). 
Flow Cytometry Analysis.  2  X  10  s COS-7 cells that had been 
transfected 48 h  earlier with cDNAs for FcyRIIla and y  chain, 
FcyRllIb, or the FcyRIIIa GPI mutant were sequentially incu- 
bated  with  anti-FcyRIII  mAb  3G8  and  with  FITC-labeled 
F(ab')2 fragments of goat anti-mouse IgG, and were analyzed on 
an Elite EPICS  Profile flow cytometer (Coulter,  Hialeah,  FL). 
Fluorescence data from 10,000 cells were expressed as the number 
of positive cells (percentage  of the  cells brighter than  the  mock- 
transfected  COS-7  cells) and as the  mean  fluorescence intensity 
(MFI) of the positive cells. 
Results 
The AflJnity for Ligand of Both  the  Human  and the Murine 
Fc~/RI Increased when the Receptors were Cotransfected with the 
T-Chain Subunit in COS Cells.  Both  the  human  and  the 
murine FcyRI cDNAs were transfected into COS cells either 
alone or with ",/chain, and the affinity of Fc',/RI for IgG was 
measured in ligand-binding assays using 12SI-labeled IgG2a, 
a murine IgG isotype that both species of FcyRI bind with 
high  affinity  (11).  The  saturation  binding data,  corrected 
for  nonspecific  binding  and  analyzed  by  the  Scatchard 
method,  produced  a  straight  line  for  both  the  human 
FcyRI and routine Fc'yRI COS  cells transfected with and 
without y  chain, which is indicative of a single population 
of receptors  with  a  single  affinity  for  IgG  (Fig.  1).  The 
equilibrium association constants  (K~) of the  Fc~/RI trans- 
fectants  were  determined  from  the  slope  of the  line  ob- 
tained in the Scatchard plots (Table 1). The human and the 
murine  FcyRI  transfected  into  COS  cells bound  mono- 
meric IgG2a with a K a of 3.2  +  0.3  ￿  107 M -1 and a K~, of 
4.9  +  0.4  X  107 M -1, respectively (Table 1), similar to af- 
finities previously reported for  these  transfectants  (8,  14). 
The  affinity for the ligand of Fc~/RI expressed in  another 
fibroblast cell line, a murine 3T3  cell line stably transfected 
with a human FcyRI cDNA, was found to be nearly iden- 
tical, with a K a of 3.5  ￿  107 M -~. 
When the human y  chain was cotransfected with hulnan 
Fc'yRI in COS cells, the binding affinity of the receptor for 
monomeric IgG2a was increased fivefold to a K~ of 15.6  X 
107 M -1  (Fig. 1 and Table 1). The binding affinity of FcyRI 
expressed on  IFN-',/-treated U937  cells, a  human  mono- 
cytic  cell line  that  naturally  expresses both  FcyRI  and  ",/ 
chain, was also measured and an average K, of 19.0  ￿  107 
M  1 was found, which was in agreement with previous re- 
ports (11)  and very similar to the binding affinity measured 
on the COS cells cotransfected with the human  Fc~/RI and 
-/chain. 
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Figure  1.  Scatchard plots  of 
monomeric IgG binding to hu- 
man  and  murine  Fc3~RI trans- 
fected with and without ",/chain 
in COS-7  cells. The  Scatchard 
plot  of one  representative  1251- 
IgG2a  ligand  binding  assay  is 
shown in which all points were 
done in triphcate  and corrected 
for nonspecific binding, demon- 
strating the binding of ligand by 
FcT,  RI transfected alone  ([-7) or 
with  ~/  chain  (@). (/t)  Human 
FcyRl (hFcTRl) with and with- 
out  human  ~/  chain  (h31). (B) 
Murine  Fc"/RI  (mFcyR1) with 
and without murine "/chain (my). 
B, bound, molar  concentrations 
of 12sI-IgG2a  bound specifically  to 
transfectants; F, free, molar con- 
centration of unbound 12sI-IgG2a. 
Table 1.  Equilibrium Association Constants for Binding of 
Monomeric IgG to FcTRI with and without T Chain 
Cell type 
Affinity for 12sI-lgG2a 
Human  Murine 
Transfected 
cDNA  K~ (107 M -1)  n  K, (107 M -1) 
U937 
P388DI 
N10F7 
COS-7 
19.0  2 
Fc',/RI  3.5  2 
Fc',/RI  3.2 -+ 0.3  13 
FcT,  RI +  hy  15.6 +  1.4"  10 
Fc~/RI +  m'y  14.5  2 
Fc',/RI + 
control  3.2 -  0.3  9 
FF  6.9 +  0.8  3 
FF +  hy  20.3  •  4.3*  3 
11.0' 
4.9 +  0.4  6 
9.2  2 
9.1  +  0.3*  5 
4.1  -+ 0.7  3 
The results are tabulated from ligand-binding  assays and Scatchard anal- 
yses of the binding of monomeric ~25I-IG2a  to various cell types and 
COS-7  cells transfected  with human or murine FcyRI cDNAs or a 
truncated form of Fc"/RI lacking the cytoplasmic domain (FF), with or 
without human or murine -/ chain (h%  my) cotransfection.  Control 
cDNAs (control) cotransfected  with Fc"/RI  were the human mannose 
receptor cDNA and several expression vectors.  K  a represent  the mean 
of n ligand-binding  assays +-- SEM. 
*The differences in the affinities of Fc~/RI for IgG that were measured 
when the receptor was transfected with or without the ~/ chain were 
statistically significant, as determined by the Student's two-tailed t test, 
with P <0.001 for hFcyRI and ~<0.001 for mFcyRl. 
*The affinity of the mFc~Rl expressed on the murine macrophage  cell 
hne P388DI, as reported by Unkeless et al. (12). 
Similar  results  were  obtained  with  the  murine  Fc',/RI 
cotransfected with ",/chain in COS  cells. Cotransfection of 
the murine ~/chain induced a twofold increase in the affin- 
ity of the receptor for mlgG2a, with a  K~ of 9.1  +  0.3  ￿ 
107 M -1, an affinity that is comparable to the one reported 
on the murine macrophage  cell line P388DI,  which had a 
K a of 11.0  ￿  107  M -1  (12).  The difference in binding af- 
finities for both the human and the murine Fc~RI that was 
measured when the receptor was  transfected alone or with 
y  chain in COS cells was demonstrated to be statistically sig- 
nificant when analyzed by Student's two-tailed t test. 
The human and the murine ~/ chains, which share  86% 
amino acid identity (15), substituted equally for each other 
in  increasing  the  binding affinity of Fc~/RI.  The  human 
Fc~/RI cotransfected with the murine ~/chain showed a K~ 
of 14.5  ￿  107 M -1, which is almost identical to the affinity 
that  was  measured when  cotransfected  with  the  human y 
chain.  The  binding affinity of the  murine  FcyRI,  when 
cotransfected with the human ",/chain, was also nearly iden- 
tical to what was measured when the receptor was cotrans- 
fected with the murine y  chain, a K~ of 9.2  ￿  107 M -1. 
To exclude the possibility that the increase in binding af- 
finity  of  Fc~/RI  for  ligand  was  a  nonspecific  effect  of 
cotransfection,  both  the  human  and  the  murine  FcyRI 
were cotransfected in COS cells with several control cDNAs, 
including the human macrophage mannose receptor cDNA 
and  several  expression  vectors,  pHMR,  pRSVCAT,  and 
pcDNAI. The binding of these FcyRI transfectants was an- 
alyzed  as  before,  and  the  resulting K,  determined by  the 
Scatchard  method were  3.2  +  0.3  ￿  107  M -t  and 4.1  + 
0.7  ￿  107 M -1 for human and murine Fc~/RI, respectively, 
when  cotransfected  with  nonspecific  cDNA  (Table  1). 
Thus,  cotransfection of nonspecific cDNA  did not change 
the affinities of human and murine Fc~/RI. 
Cotransfection of the  7t  chain with  human  Fc~/RI  also 
appeared  to  affect  the  number  of  expressed  receptors. 
2229  Miller et al. Binding of monomeric  IgG2a to  COS  cells cotransfected 
with  human  FcyRI and y  chain  showed  a  consistent de- 
crease in the total concentration of receptor sites, as shown 
by  the  Bma  ~  values:  5.0  +  1.0  ￿  10 -1~  M  for  FcyRI 
cotransfected with y  chain,  as compared to  16.0  +  4.0  ￿ 
10 -*~ M  when FcyRI was transfected alone, or 13.0 +  1.0 ￿ 
10 -m M  when  it was  cotransfected with  control cDNAs. 
Although the expression levels in transient transfectants can 
be variable, the consistency with which y  chain decreased 
the Bin,  ~ of the human FcyRI suggested that the change in 
the  concentration  of  receptor  sites  may  be  specific  to 
y-chain cotransfection.  Unlike the human  receptor, how- 
ever, the Bm~  x measured for the murine FcyRI cotransfected 
with "y chain was not different from the Bm~  x obtained with 
FcyRI alone. 
The Changes in Binding Affinity for IgG Correlate with the As- 
sociation oft Chain with FcTRI.  We  have  previously shown 
that  the  association of the  human  FcyRI  with  human  y 
chain  can  be  reconstituted in  COS  ceils  (3).  To  confirm 
that this association was present in our experimental condi- 
tions  and  to  determine  if the  murine  FcyRI  association 
with the murine y  chain was also reconstituted in COS cell 
transfections, we analyzed transfectants by Western blot af- 
ter  immunoadsorption  with  antibodies  against  human 
FcyRI (197)  or y  chain  (4D8)  (Fig. 2). Since antibody 197 
is an  IgG2a isotype, it was  also used  as a  ligand to  adsorb 
the murine FcyRI because of the lack of specific antibodies 
for  this  receptor.  The  anti-y-chain immunoblot  antibody 
recognized a  10-kD protein copurifying with FcyRI in  im- 
nmnoadsorbates from  cells transfected with  human  FcyRI 
and human y  chain (Fig. 2 A, lane 2), and from cells trans- 
fected with nmrine  FcyRI and human  y  chain  (Fig. 2  A, 
lane  4).  A  band  that  was  the  appropriate size for y  chain 
was also copurified from cells in which  the human  FcyRI 
was cotransfected with  the murine y  chain  (Fig. 2  B,  lane 
4),  as  well  as  from  cells  cotransfected  with  the  murine 
FcyRI and  the  murine  y  chain  (Fig.  2  B,  lane  5).  Direct 
immunoadsorption ofy chain with anti-y-chain n~Ab 4D8 
confirmed the presence  of y  chain  in the  appropriate ceils 
(Fig. 2 A, lanes 2 and 4, and B, lanes, 4 and 5). 
The Association of FcTRI with Y  Chain and the Subsequent 
Increase in  Binding  Affinity  are Independent  of the  Cytoplasmic 
Domain of the Receptor.  To  investigate  if  the  transmem- 
brane  domain of FcyRI was sufficient for association with 
y  chain as well as for the increase in binding affinity medi- 
ated  by  y  chain,  a  truncated  form  of the  human  FcyRI 
containing the extracellular and transmernbrane domains of 
the  receptor  without  the  cytoplasmic  domain  (FF)  was 
constructed and transfected into COS ceils with or without 
y  chain.  Western  blot analysis with  an  anti-y-chain anti- 
body showed a  10-kD  band  (Fig. 2  A, lane  7) in cells that 
had been cotransfected with the truncated construct and y 
chain,  and  immunoadsorbed  with  either  anti-FcyRI  or 
anti-y-chain  antibodies,  indicating  that  y  chain  was  ex- 
pressed in these cells and was coimmunoadsorbed with the 
truncated FcyRI mutant. 
The increase in binding affinity of FcyRI induced by y 
chain  was  not  affected by the  absence  of the  cytoplasmic 
Figure 2.  FcyRI association  with ~/chain in COS-7 transfectants.  Dig- 
itonin lysates of COS-7  cells transfected (COS Tf) with  human Fc'yRl 
(hR/) or murine FcyRI (mR/) with or without  the human y chain (hT) 
(A, lanes 1-5), and with or without the murine y chain (my) (B, lanes 1-5) 
were immunoadsorbed (IA) with anti-hFc~/Rl (>Fc'yRI, mAb  197; A, 
one-half the volume of the lysates; B, two-thirds the volume of the ly- 
sates) and anti-y-chain m_Ab 4D8  (>3,). Lanes 6 and 7 in A are from a 
separate experiment that shows the association  ofy chain with a truncated 
human  Fc',/RI mutant  lacking its cytoplasmic domain  (FF) transfected 
with or without the human 3' chain. The eluates were analyzed by West- 
ern blot with rabbit anti-y-chain antibody and ECL detection. Lanes 3, 
4,  and  5 in A,  >FcyRI are from a longer exposure time.  Molecular 
masses of protein standards  are indicated in kilodaltons. 
domain  of the  receptor.  COS  cells  transfected  with  the 
truncated FcyRI alone bound monomeric  12sI-IgG2a with 
a /Ca of 6.9  +  0.8  ￿  107 M -1, whereas after cotransfection 
with y  chain, cells bound 12sI-IgG with a K~ of 20.3  +  4.3 
￿  107 M -1  , similar to the K a of 19.0  X  107 M -I that was 
measured for FcyRI on U937 cells (Table 1), indicating that 
the  cytoplasmic domain  of FcyRI  is  not  required  for  en- 
hanced binding affinity. The binding affinity of the truncated 
FcyRI transfected without y  chain was twofold higher than 
that of the wild-type receptor (P =  0.025); however, no sig- 
nificant difference was seen in the affinity of the two recep- 
tors that were cotransfected with y  chain (P =  0.400). 
Association with y  Chain Confers Medium Affinity Binding to 
FcyRIII.  To determine if the medium affinity of FcyRIIIa 
2230  y Chain Increases FcyR Afl3nity for  monomeric  IgG  is  caused  by  its  association  with  "/ 
chain, COS ceils were transfected with either the FcyRIIIa 
isoform, which requires cotransfection and association with 
"y chain  for ceil-surface  expression,  or the  Fc~RIIIb iso- 
form, a GPI-linked form of the receptor that does not asso- 
ciate with "y chain.  We also transfected an FcyRIIIa mu- 
tant, resulting in a GPI-linked form of the receptor whose 
expression  was  independent  of ~/-chain  association.  The 
three Fc~RIII constructs transfected in COS cells were an- 
alyzed simultaneously for ligand affinity by IgG-binding as- 
say and for expression by flow cytometry. Table 2  shows 
the results of representative Scatchard and flow cytometric 
analyses of the same set of transfected COS ceils,  compar- 
ing  ligand  binding  affinity  and  surface  expression  of the 
three Fc~/RIII. The affinity of FcyRIIIa cotransfected with 
y  chain  (1.2  X  107  M -l)  demonstrated  an  ~10-fold  in- 
crease  when  compared  to  the  affinity  measured  for  the 
FcyRIlla GPI mutant  (0.1  ￿  107 M-l),  while the affinity 
of Fc~RIIIb could  not  be  calculated  because  of the  low 
level ofligand binding. The expression of the three Fc~/RIIIs 
was analyzed with an anti-FcyRIII antibody by flow cytom- 
etry to insure that the lower binding and affinities  that were 
measured for FcyRllIb and FcyRIIIa GPI were not caused 
by  low  levels  of expression  (Table  2).  The  three  Fc',/R 
were expressed in  COS  ceils,  with Fc',/RIIIa/~/ chain ex- 
pressing less  than the  Fc3~RIIIb or Fc',/RIIIa-GPI mutant, 
confirming an absence of correlation between binding af- 
finity and levels of receptor expression. Similar results were 
obtained in two  additional  ligand-binding  assays and flow 
cytometric analyses. 
Discussion 
The functions that the 3, chain provides in its association 
with  FcyR continue  to be defined.  We have now shown 
that y  chain, in addition  to its roles in receptor expression 
Table 2.  Analysis  of Ligand Binding and Expression of FcyRllI 
Transfected in COS-7 Cells 
Expression 
Binding affinity 
Transfectant  K~ (10 7 M -l)  % +  cells  MFI 
Fc3,RllIa  +  y  1.2  10.9  28.5 
Fcy RIIIb  <0.1  22.0  62.6 
Fcy RIlla GPI mutant  0.1  22.1  56.3 
Equilibrium association constants of one representative ligand-binding 
assay ofmonomeric I25I-tgG2a  to COS-7 cells transfected with FcyRIlla 
and the ~/ chain, Fc',/RIIlb, and an Fc~/RIIIa  GPI mutant, each point 
done in triplicate as described in Fig. 1. The surface expression of the 
three Fc3,RIII constructs from the same set of transfected COS-7 cells 
was analyzed in flow cytometry with the anti-Fc'yRllI mAb 3G8. The 
results are expressed  as the mean of the percentage of cells brighter than 
negative controls (% + cells) and the MFI of the positive cells. Similar 
results were obtained in two additional ligand-binding assays and flow 
cytometric analyses. 
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and signal transduction,  modifies the  affinity of FqR  for 
ligand. In this study, we demonstrated that the high affinity 
for monomeric IgG that characterizes both the human and 
murine FcyRI was dependent upon ",/-chain  cotransfection 
with the receptor, thus explaining the discrepancy between 
the lower binding  affinity reported  for FcyRI transfected 
into  COS  ceils  and  the  higher  affinity measured  on  ceils 
that naturally express the receptor. Association of'y chain 
increased  the  binding  affinity  of human  FqRI  fivefold, 
and the affinity of the murine receptor twofold. While the 
level  of affinity increase  was  lower  in  the  mouse,  the  y 
chain brought the affinity of both species of FcyRI to the 
levels reported on ceils  that naturally express the receptors. 
The differences observed between the human and the murine 
FcyRI when cotransfected with 21 chain in COS  cells  did 
not appear to be related to the species of y  chain that was 
cotransfected with the receptors, since similar results were 
obtained when each receptor was cotransfected with the y 
chain from the other species, suggesting differences within 
the  structure  of the  receptors  themselves.  In fact,  the  re- 
ported range of binding affinity for the human FcyRI, Ka 
of 108-9 M -1  (10),  is  slightly higher  than  the  affinity re- 
ported on murine macrophages,/Ca of 1.1  ￿  108 M -1 (12), 
an observation our data supports. Our findings also suggest 
that  the  Fc~/RIIIa isoform, the  "medium affinity"  Fc~/R, 
has a higher affinity for monomeric IgG than the Fc-/RIIIb 
isoform because of its association with "y chain. The affinity 
of an  Fc',/RIIIa GPI  mutant,  expressed  without  the  re- 
quirement of the y  chain, was 10-fold less than the affinity 
measured for FcyRIIIa cotransfected with the y  chain. 
We  had  previously  postulated  that  y  chain  associated 
with Fc',/RI through the transrnembrane domain of the re- 
ceptor due  to  homology of this  region  to  the  transmem- 
brane domains of FceRl and Fc',/RItla (3),  both shown to 
associate  with  y  chain  through  their  transmembrane  do- 
mains (16).  With only five putative extracellular amino ac- 
ids  (15), it is unlikely that ~/chain associated  with Fc',/RI or 
induced its change in affinity through an interaction at the 
extracellular level. Analysis of a truncated Fc~/RI lacking its 
cytoplasmic domain not only supported the hypothesis that 
~/ chain associated with the transmembrane domain of the 
receptor,  but  also  demonstrated  that  the  cytoplasmic do- 
main  of the  receptor was  not  required  for the  increased 
binding affinity conferred by association with ",/ chain.  In 
fact, we observed a slight but significant increase in the af- 
finity of the truncated Fc',/RI when compared to the wild- 
type  Fc',/RI, which  suggests  that  the  cytoplasmic domain 
may actually have an inhibitory effect upon binding affin- 
ity. When  the receptors were cotransfected with y  chain, 
however, there was no longer a significant difference in the 
binding  affinity of the  truncated  Fc2cRI  compared to  the 
wild-type  receptor,  suggesting  "/-chain  association  may 
overcome any inhibitory effect of the  Fc',/RI cytoplasmic 
domain  to  confer  the  appropriate  receptor  structure  for 
high affinity binding. 
It has been inferred previously that the unique third ex- 
tracellular domain of Fc~/RI is responsible for its high affin- 
ity binding of monomeric IgG (8,  14).  In one study, a mu- rine  Fc`/R chimera lacking the  third  extracellular domain 
and containing only the first two extracellular domains of 
Fc',/RI spliced to the transmembrane and cytoplasmic do- 
main of Fc`/RII bound IgG with the same low affinity and 
binding specificity as Fc~/RII (13).  While we have shown 
that `/ chain association is required for maximum binding 
affinity, Fc`/RI expressed without  the ",/ chain still  bound 
IgG with an affinity higher than the other Fc~/R, indicating 
that the high affinity binding of this receptor may be a re- 
sult  of contributions  from the  extracellular  domain  along 
with the association to the -/-chain subunit. The role of the 
extracellular domain was also apparent in our Fc`/RIII ex- 
periments. Both of the two GPI-linked forms ofFcyRIII, a 
and b, bound ligand with low affinity; however, the affinity 
of  Fc~/RIIIa  could  be  measured,  while  the  binding  of 
FcyRIIIb was too low for an accurate affinity to be deter- 
mined,  even though  the  two  receptors were  expressed at 
similar  levels.  These  findings  suggest  that  the  six-amino 
acid differences between the extracellular  domain of Fc~/RIIIa 
and Fc'yRIIIb (17),  in addition to association with `/chain, 
contributed to the higher binding affinity of this receptor. 
For both Fc~/RI and FcyRIII, it appeared that the structure 
of the  extracellular  domains  affects binding  affinity,  and 
that  association with -/ chain further increases the  affinity 
for ligand,  probably through  a  change  of the  quaternary 
structure of the receptors. 
While  increased  binding  affinity  due  to  an  associated 
subunit is a novel observation among FcyR, a similar phe- 
nomenon has been described for members of the cytokine 
receptor family. Like Fc~/R, hematopoietic cytokine recep- 
tors  are  characterized by pleiotropy and  redundancy,  and 
lacking a tyrosine signaling motif in their cytoplasmic do- 
main,  they  associate  with  common  subunits  including 
gp130, KH97, and the IL receptor "y chain (18-22), which 
are responsible for mediating the receptor signal. Like Fc~/RI, 
these cytokine receptors when expressed alone bind ligand 
with relatively low affinity but are transformed to high affin- 
ity receptor complexes upon association with their subunits. 
An explanation has been proposed for the affinity increase 
of these receptors upon association with the signaling sub- 
unit:  receptors  that  do  not  have built-in  signaling  motifs 
and instead  rely upon  associated subunits  might require  a 
higher binding affinity for ligand to give the receptor the 
time that is necessary to transmit signals through the associ- 
ated subunit  (18).  This hypothesis may also be relevant to 
Fc~/R,  since  Fc~/RII,  which  contains  a  signaling  motif 
within its cytoplasmic domain, binds monomeric IgG with 
lower  affinity than  Fc`/RI  and  Fc~/RIIIa, both  of which 
rely on association with the `/ chain to transmit signals  to 
the cell.  It would appear that the ability of the ~/chain to 
modify the affinity of Fc2cR  for ligand is not only a novel 
observation among FcR, but it may also have a wider sig- 
nificance, suggesting that in addition to their roles in signal 
transduction,  associated  subunits  may  regulate  receptor- 
ligand interaction. 
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